Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000667054 | SCV000791447 | uncertain significance | Glucose-6-phosphate transport defect | 2017-05-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003278980 | SCV003989566 | uncertain significance | Inborn genetic diseases | 2023-04-18 | criteria provided, single submitter | clinical testing | The p.L151P variant (also known as c.452T>C), located in coding exon 3 of the SLC37A4 gene, results from a T to C substitution at nucleotide position 452. The leucine at codon 151 is replaced by proline, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |